Why CCHH Stock dropped -7.37% Today — RQD Quant Desk Flash

Per the Roarable RQD rating, CCHH carries an RQD Score of 22 out of 100, a letter grade of E, and the verdict label "Roarable Strong Sell — Forensic Risk / Avoid." The five pillars are scored as follows:

• Fundamental Cash Engine: 5 / 20. The rating cites ROIC of -21.4% and an FCF yield of -3.97%. For a prospective investor, this indicates the business is not currently generating cash returns on invested capital; any valuation case must rest on a turnaround rather than existing cash generation.
• Whale 13F Flow: 5 / 20. The rating's description references institutional accumulation and options positioning, but the holders section contains no filings, so the score cannot be traced to specific institutional activity in this dossier.
• Insider Conviction: 3 / 20. The lowest pillar, reflecting SEC Form 4 and Congressional PTR cluster flow per the rating description. The underlying transactions are not provided in the source data, so the investor implication is limited to the fact that the rating assigns weak insider conviction.
• Macro Regime Fit: 5 / 20. The rating cites a beta of 1.0 and sector sensitivity. A beta of 1.0 means the stock is modeled to move in line with the broad market, offering no defensive cushion or asymmetric upside from the market factor alone.
• Forensic Balance Sheet: 4 / 20. The rating cites an Altman Z-Score of 1.89, a Piotroski F-Score of 3/9, and a Debt/Equity ratio of 0.5. These point to elevated financial distress and weak fundamental quality signals, which is the primary driver of the "Forensic Risk" label.

Taken together, the rating frames CCHH as a high-risk, low-quality setup. The upside drivers a prospective investor would need to see are a reversal in operating losses and a return to positive ROIC and free cash flow; none is evidenced in the current data. The valuation tradeoff is that a price of $0.96 and a $19.0M market capitalization can look inexpensive in isolation, but the negative cash returns and weak forensic scores suggest the low price reflects fundamental impairment rather than a mispricing.

CCH Holdings Ltd (Class A) is a NASDAQ-listed issuer in the Consumer Discretionary sector and Restaurants industry, per the profile. The source data does not describe its products, customers, or revenue model. Reported revenue of $9.6M for FY 2025 and a gross margin of 19.3% per the market data indicate restaurant-industry operations at small scale, but the specific business lines are not available in source data.

Per the SEC financials, revenue was broadly flat across the three periods, while operating income swung from $0.8M to $1.3M and then to $-2.4M in FY 2025. The market data reports an operating margin of -24.6%, a net margin of -28%, and an ROIC of -21.4%. Per the Roarable RQD rating, the Altman Z-Score is 1.89, the Piotroski F-Score is 3/9, and Debt/Equity is 0.5, signaling a weak balance sheet posture. Debt is not reported in the period data.

Per the recent news feed, a single item exists: a TradingView report titled "CCH Holdings Ltd Estimates – NASDAQ:CCHH," published one hour before the data timestamp, flagged with a yellow light and a "MARKET WIRE" impact label. The summary is generic and does not state any specific event, estimate, or catalyst. Per the Butterfly Supply-Chain Graph, no supply-chain links or proprietary signals are recorded. Risk watch items, based on the financials, include the FY 2025 swing to operating and net losses and negative free cash flow.

Per the Butterfly Supply-Chain Graph, the supply chain is recorded as "NONE," with no butterfly links and no proprietary signals. Upstream suppliers, downstream customers, and sector correlations are therefore not available in source data. The sector and industry classification (Consumer Discretionary / Restaurants) is the only contextual link provided.

• What are CCHH's specific restaurant operations, locations, and revenue drivers behind the FY 2025 swing to operating losses?
• What is the debt balance and maturity profile, given that debt is not reported in the period data despite a reported Debt/Equity ratio of 0.5?
• What drove the stock's 52-week range from $0.83 to $153.9, and does this reflect a corporate action or a reporting anomaly?
• What are the TTM and forward earnings figures, which are not available in source data, needed to assess valuation?
• What is the nature of the TradingView "Estimates" report, and does it contain any quantified estimate for revenue or earnings?